Placeholder Banner

Letter in support of U.S. Codex Office funding

May 30, 2023

BIO joined with more than 40 groups in calling on Congress to set 2024 funding for the U.S. Codex Office at or above the 2023 level. 

Download Full Comments Below
Letter Re: U.S. Codex Office Funding

Letter to Senate Ag Appropriations chair and ranking member to urge full and adequate funding for the U.S. Codex Office in fiscal 2024.

Discover More
BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill. 
In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.